Economic analysis of alvimopan--a clarification and commentary
Pharmacotherapy
.
2013 May;33(5):e81-2.
doi: 10.1002/phar.1193.
Epub 2012 Oct 12.
Authors
Timothy J Bell
1
,
Sara A Poston
,
Michael D Kraft
,
Anthony J Senagore
,
Lee Techner
Affiliation
1
Global Health Economics and Outcomes Research, Pfizer Inc., New York, NY, USA.
PMID:
23065817
DOI:
10.1002/phar.1193
No abstract available
Publication types
Comment
MeSH terms
Humans
Ileus / economics*
Ileus / prevention & control*
Piperidines / economics*
Piperidines / therapeutic use*
Postoperative Complications / economics*
Postoperative Complications / prevention & control*
Substances
Piperidines